A Digital Lifeline for Adult ADHD: CBT-Based App Proves Effective in Major Trial
A new randomized controlled trial demonstrates the significant effectiveness of a fully self-guided digital intervention for adults with attention-deficit/hyperactivity disorder (ADHD). The study, published in Psychological Medicine, evaluated “attexis,” a mobile application grounded in cognitive behavioral therapy (CBT) and mindfulness principles, as an adjunct to standard treatment. Involving 337 adults with confirmed ADHD, the trial found that those using the app alongside treatment as usual showed a substantial reduction in core ADHD symptoms after three months compared to the control group, with a large effect size. The intervention also led to meaningful improvements in functional impairment, depressive symptoms, self-esteem, and overall quality of life, with benefits sustained at a six-month follow-up. This research addresses a critical gap in accessible, evidence-based psychosocial support for ADHD, offering a scalable solution that requires no clinician guidance.
Study Significance: This trial provides robust evidence for a scalable digital tool that can directly expand access to first-line psychosocial treatment for ADHD, a condition where demand far outpaces clinical capacity. For psychiatrists and mental health providers, integrating such validated digital cognitive behavioral therapy options into treatment plans offers a practical method to enhance patient outcomes and provide continuous support between sessions. It represents a strategic shift towards hybrid care models in psychiatry, leveraging technology to deliver effective interventions for mood disorders and neurodevelopmental conditions like ADHD efficiently.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
